ONKI3 | Medical Subject Headings

The ONKI is provided as a part of the ONKI Living Lab - an open lab for testing the latest semantic web technologies in practice, with real users like you. Currently, over 10 000 people are using ONKI each month.

We hope you like the ONKI service and enjoy using it for your purposes!

If you encounter any problems or have improvement ideas, please contact the ONKI team. We are also very much interested in your success stories in using ONKI - please share your experiences!

The ONKI Team

Jouni Tuominen, Living Lab contact person, APIs, widgets, publishing of ontologies, etc.
Eero Hyvönen, professor, head of research group

Former members: Kim Viljanen, Rami Alatalo.

Building the future of the Semantic Web and beyond.

SeCo's homepage
For the latest semantic news, follow us on Twitter and fan us on Facebook!

How can we help you?

Live presentations about ONKI: what it is? how to use it?
Support for creating and publishing ontologies.
Online technical support for using ONKI.
Co-operation in projects.
And more, please ask.


Hierarchy:	Medical Subject Headings (MeSH) ∟ Amino Acids, Peptides, and Proteins ∟ Peptides ∟ Peptides, Cyclic ∟ Streptogramins 21 coordinate concepts 6 subordinate concepts ∟ Mikamycin \| ∟ Pristinamycin \| ∟ Streptogramin Group A \| ∟ Streptogramin Group B \| ∟ Vernamycin B \| ∟ Virginiamycin ∟ Alamethicin \| ∟ Amanitins \| ∟ Bacitracin \| ∟ Capreomycin Sulfate \| ∟ Cyclosporins \| ∟ Cyclotides \| ∟ Dactinomycin \| ∟ Daptomycin \| ∟ Depsipeptides \| ∟ Echinomycin \| ∟ Ferrichrome \| ∟ Microcystins \| ∟ Mycobacillin \| ∟ Nanotubes, Peptide \| ∟ Nisin \| ∟ Octreotide \| ∟ Phalloidine \| ∟ Polymyxins \| ∟ Thiostrepton \| ∟ Tyrothricin \| ∟ Viomycin Medical Subject Headings (MeSH) ∟ Polycyclic Compounds ∟ Macrocyclic Compounds ∟ Peptides, Cyclic ∟ Streptogramins 21 coordinate concepts 6 subordinate concepts ∟ Mikamycin \| ∟ Pristinamycin \| ∟ Streptogramin Group A \| ∟ Streptogramin Group B \| ∟ Vernamycin B \| ∟ Virginiamycin ∟ Alamethicin \| ∟ Amanitins \| ∟ Bacitracin \| ∟ Capreomycin Sulfate \| ∟ Cyclosporins \| ∟ Cyclotides \| ∟ Dactinomycin \| ∟ Daptomycin \| ∟ Depsipeptides \| ∟ Echinomycin \| ∟ Ferrichrome \| ∟ Microcystins \| ∟ Mycobacillin \| ∟ Nanotubes, Peptide \| ∟ Nisin \| ∟ Octreotide \| ∟ Phalloidine \| ∟ Polymyxins \| ∟ Thiostrepton \| ∟ Tyrothricin \| ∟ Viomycin X
Broader terms:	Medical Subject Headings (MeSH) ∟ Amino Acids, Peptides, and Proteins ∟ Peptides ∟ Peptides, Cyclic ∟ Streptogramins Medical Subject Headings (MeSH) ∟ Polycyclic Compounds ∟ Macrocyclic Compounds ∟ Peptides, Cyclic ∟ Streptogramins Peptides, Cyclic > Peptides > Amino Acids, Peptides, and Proteins > Medical Subject Headings (MeSH) Peptides, Cyclic > Macrocyclic Compounds > Polycyclic Compounds > Medical Subject Headings (MeSH) X
Narrower terms:	Mikamycin \| Pristinamycin \| Streptogramin Group A \| Streptogramin Group B \| Vernamycin B \| Virginiamycin X
History note:	Virginiamycin (1992-2001)X
historyNote*:	2002, 1981-1993; use VIRGINIAMYCIN 1994-2001 X
publicMeSHNote*:	2002; see VIRGINIAMYCIN 1994-2001, see STREPTOGRAMINS 1981-1993 X
Scope note:	A class of natural cyclic peptide antibiotics produced by certain subspecies of STREPTOMYCES. They include two structurally unrelated components, STREPTOGRAMIN GROUP A and STREPTOGRAMIN GROUP B, which generally act synergistically to inhibit bacterial growth. X
activeMeSHYear*:	2005 \| 2006 \| 2007X
dateCreated*:	2001-07-25X
dateEstablished*:	2002-01-01X
dateRevised*:	2004-07-07X
recordAuthorizer*:	sjnX
recordMaintainer*:	ssbX
recordOriginator*:	jmpX
Type:	Concept X
Coordinate terms:	Alamethicin \| Amanitins \| Bacitracin \| Capreomycin Sulfate \| Cyclosporins \| Cyclotides \| Dactinomycin \| Daptomycin \| Depsipeptides \| Echinomycin \| Ferrichrome \| Microcystins \| Mycobacillin \| Nanotubes, Peptide \| Nisin \| Octreotide \| Phalloidine \| Polymyxins \| Thiostrepton \| Tyrothricin \| Viomycin X
URI:	X
Labels and equivalent concepts:	Streptogramiinit (fi) Streptogramiini (fi, replaced) Streptograminer (sv) Streptogramin (en, replaced) X
Share:	X